COVID-19

News

Cipla launches COVID-19 drug remdesivir in India as disease ...

Efforts to get Gilead’s experimental COVID-19 drug remdesivir to patients in badly-hit India are building after drug maker Cipla announced it had launched the drug in the country.

Views & Analysis

Coronavirus pharma news roundup – 19/06/20

We highlight the top coronavirus news stories in pharma R&D, digital and market access news from the past week.

News

Mixed results for Roche drugs in prostate cancer and COVID-1...

Two eye-catching research projects involving drugs from Roche have produced disappointing trial results, after its prostate cancer drug achieved only one of its targets and its inflammatory

Views & Analysis

Healthcare’s ‘2008 banking moment’: What has COVID taught us...

COVID-19 has changed many elements of healthcare – from mental health to social care, from vaccines to virtual clinics.

News

Hilversum, The Netherlands - April 03, 2014. Image of a touch screen Android phone with social media apps.

Social media users more likely to break COVID-19 lockdown ru...

People who get information about coronavirus from social media platforms such as Facebook and YouTube are more likely to believe conspiracy theories about COVID-19 and to have broken lockdo

News

US left with huge hydroxychloroquine stockpile after COVID-1...

The US has been left with a huge stockpile of hydroxychloroquine, after the World Health Organization abandoned research into the drug as a treatment for COVID-19.

Cipla launches COVID-19 drug remdesivir in India as disease ...

Coronavirus pharma news roundup – 19/06/20

Mixed results for Roche drugs in prostate cancer and COVID-1...

Healthcare’s ‘2008 banking moment’: What has COVID taught us...

Social media users more likely to break COVID-19 lockdown ru...

US left with huge hydroxychloroquine stockpile after COVID-1...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

COVID-19

Editor's Picks